CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 250 shares (option exercise)
- 4 Grant or award Director acquired 893 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Grant or award Chief Science Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 80,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 16,000 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Former 10% owner sold 3,100,000 shares at $102.50 ($317,750,000)
- 8-K/A Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
Page 1 of 28 · 542 filings